Ivabradine/metoprolol - Servier

Drug Profile

Ivabradine/metoprolol - Servier

Alternative Names: IMPLICOR; Metoprolol/ivabradine

Latest Information Update: 06 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Servier
  • Class Antihypertensives; Benzazepines; Bradycardic agents; Class II antiarrhythmics; Heart failure therapies; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Propanolamines; Small molecules
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Angina pectoris

Most Recent Events

  • 06 Nov 2015 Registered for Angina pectoris in Netherlands, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Liechtenstein, Lithuania, Malta, Norway, Poland, Romania, Slovenia, Sweden, Slovakia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top